Jun 14, 2022 (AmericaNewsHour) -- Research Nester released a report titled " RNAi Technology Market : Global Demand Analysis & Opportunity Outlook 2027" which delivers detailed overview of the global RNAi technology market in terms of market segmentation by therapy area, by application and by region.
Further, for the in-depth analysis, the report encompasses the industry growth drivers, restraints, supply and demand risk, market attractiveness, BPS analysis and Porter's five force model.
According to the National Cancer Institute, it was estimated that in 2018, around 1,735,350 new cases of cancer would be diagnosed in the United States, out of which, 609,640 people were estimated to die from the disease.
The market for RNA interference technology is estimated to observe a significant CAGR of around 15% during the forecast period, i.e., 2019-2027. RNAi technology, when used in therapeutics, inhibits the expression of genes that are responsible for certain diseases including cancer and hepatitis. The market is segmented by therapy area, by application and by region, out of which, the therapy area segment is further divided into cancer, liver disorders, respiratory disorders, neurological disorders, autoimmune disorders and others. On the basis of therapy area, the cancer segment is estimated to grow at the highest rate over the forecast period as a result of rising demand for better diagnostic as well as therapeutic techniques for the treatment of cancer.
Download Sample of This Strategic Report @ https://www.researchnester.com/sample-request-2170
The market in North America is anticipated to hold the leading share in RNA interference or RNAi technology market on the back of growing incidences of diseases such as cancer and liver disorders. The presence of leading market players in the region, especially in the United States, results in the development of advanced techniques which is estimated to further raise the market growth. The market in Asia Pacific, on the other hand, is predicted to grow at the highest rate over the forecast period on account of rising awareness among people about the risks associated with various disorders.
Preference of RNAi Technology over Chemotherapy to Drive the Market Growth
Conventional cancer treatment methods such as chemotherapy are being replaced by the advanced therapeutics, for instance, RNA interference technology. RNAi technology provides a targeted approach to therapy which, unlike conventional therapies, does not harm the normal cells and impacts only the cancerous cells which is estimated to boost the market growth. However, the stringent government policies and regulations for the approval of the therapies is estimated to hinder the market growth in future.
Request a Sample Copy of Concerned Market Report @ https://www.researchnester.com/sample-request-2170
This report also provides the existing competitive scenario of some of the key players of the global RNAi technology market which includes company profiling of Alnylam Pharmaceuticals, Inc. /zigman2/quotes/205655272/composite ALNY -1.39% , Dicerna Pharmaceuticals, Inc. , Arrowhead Pharmaceuticals, Inc. /zigman2/quotes/204828235/composite ARWR -2.67% , Ionis Pharmaceuticals, Inc. /zigman2/quotes/201272020/composite IONS -0.74% , Quark Pharmaceuticals, Inc., Arbutus Biopharma /zigman2/quotes/203237619/composite ABUS -2.42% , Benitec Biopharma (asx:BLT), Calando, Silence Therapeutics (lon:SLN) and Gotham Therapeutics.
The profiling enfolds key information of the companies which encompasses business overview, products and services, key financials and recent news and developments. On the whole, the report depicts detailed overview of the global RNAi technology market that will help industry consultants, equipment manufacturers, existing players searching for expansion opportunities, new players searching possibilities and other stakeholders to align their market centric strategies according to the ongoing and expected trends in the future.
Curious about this latest version of report? Obtain Report Details @ https://www.researchnester.com/reports/rnai-technology-market/2170
About Research Nester
Research Nester is a leading service provider for strategic market research and consulting. We aim to provide unbiased, unparalleled market insights and industry analysis to help industries, conglomerates and executives to take wise decisions for their future marketing strategy, expansion and investment, etc. We believe every business can expand to its new horizon, provided a right guidance at a right time is available through strategic minds. Our out of box thinking helps our clients to take wise decision so as to avoid future uncertainties.
U.S. Phone: [+1 646 586 9123]
U.K. Phone: [+44 203 608 591]
Is there a problem with this press release? Contact the source provider Comtex at email@example.com. You can also contact MarketWatch Customer Service via our Customer Center.